WP
Waycross Partners’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-187,562
| Closed | -$12.4M | – | 65 |
|
|
2024
Q3 | $12.4M | Buy |
187,562
+20,796
| +12% | +$1.37M | 1.71% | 27 |
|
|
2024
Q2 | $15.4M | Buy |
166,766
+32,296
| +24% | +$2.98M | 2.36% | 15 |
|
|
2024
Q1 | $12.8M | Buy |
134,470
+11,149
| +9% | +$1.07M | 2.21% | 21 |
|
|
2023
Q4 | $9.4M | Sell |
123,321
-7,447
| -6% | -$568K | 1.76% | 26 |
|
|
2023
Q3 | $9.06M | Buy |
130,768
+6,833
| +6% | +$473K | 2% | 24 |
|
|
2023
Q2 | $11.7M | Buy |
123,935
+27,144
| +28% | +$2.56M | 2.54% | 14 |
|
|
2023
Q1 | $8.01M | Buy |
96,791
+17,035
| +21% | +$1.41M | 2.33% | 18 |
|
|
2022
Q4 | $5.95M | Buy |
+79,756
| New | +$5.95M | 2.16% | 18 |
|
|
2021
Q3 | – | Sell |
-35,366
| Closed | -$3.66M | – | 90 |
|
|
2021
Q2 | $3.66M | Sell |
35,366
-1,785
| -5% | -$185K | 1.95% | 20 |
|
|
2021
Q1 | $3.11M | Sell |
37,151
-3,659
| -9% | -$306K | 1.73% | 19 |
|
|
2020
Q4 | $3.72M | Buy |
+40,810
| New | +$3.72M | 2.32% | 15 |
|